Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
new york blog main
new york top stories
2
×
san francisco blog main
san francisco top stories
startups
vc
acetylon pharmaceuticals
ambys medicines
azacitidine
beta-thalassemia
boston
cell therapy
constellation pharmaceuticals
dacogen
decitabine
dna
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
gene therapy
genentech
holger willenbring
insulated genomic domains
ipo
jeffrey tong
juan carlos izpisua belmonte
kaleido biosciences
keith dionne
liver disease
mahesh karande
markus grompe
What
biotech
2
×
medicines
2
×
new
startup
aiming
aims
ambys
approach
based
big
called
control
deadly
deal
debuted
debuts
developing
diseases
drugs
epigenetic
epigenetics
field
flagship’s
formed
future
launch
liver
make
morning
omega
research
step
takeda
therapeutics
today
touting
treatments
unusual
variety
Language
unset
Current search:
biotech
×
medicines
×
" new york top stories "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
